chr11-125678121-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001612.6(ACRV1):āc.229A>Cā(p.Lys77Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001612.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACRV1 | NM_001612.6 | c.229A>C | p.Lys77Gln | missense_variant | 2/4 | ENST00000533904.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACRV1 | ENST00000533904.6 | c.229A>C | p.Lys77Gln | missense_variant | 2/4 | 1 | NM_001612.6 | A2 | |
ACRV1 | ENST00000315608.7 | c.229A>C | p.Lys77Gln | missense_variant | 2/4 | 1 | P2 | ||
ACRV1 | ENST00000527795.1 | c.122-103A>C | intron_variant | 2 | A2 | ||||
ACRV1 | ENST00000530048.5 | c.122-58A>C | intron_variant | 3 | A2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727242
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.229A>C (p.K77Q) alteration is located in exon 2 (coding exon 2) of the ACRV1 gene. This alteration results from a A to C substitution at nucleotide position 229, causing the lysine (K) at amino acid position 77 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at